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Abstract
Fluxome analysis aims at the quantitative analysis of in vivo carbon fluxes in metabolic networks, i.
e. intracellular activities of enzymes and pathways. It allows investigating the effects of genetic or
environmental modifications and thus precisely provides a global perspective on the integrated
genetic and metabolic regulation within the intact metabolic network. The experimental and
computational approaches developed in this area have revealed fascinating insights into metabolic
properties of various biological systems. Most of the comprehensive approaches for metabolic flux
studies today involve isotopic tracer studies and GC-MS for measurement of the labeling pattern
of metabolites. Initially developed and applied mainly in the field of biomedicine these GC-MS based
metabolic flux approaches have been substantially extended and optimized during recent years and
today display a key technology in metabolic physiology and biotechnology.
Background
The present review describes the use of stable isotopes,
mainly 13C, for the analysis of metabolic fluxes. In all the
approaches presented here, single or multiple labeled
molecules, i.e. applied tracer substrates or analyzed
metabolites, play an important role. Concerning the
nomenclature of such molecules labeled with stable iso-
topes there are no strict IUPAC guidelines. Labeled mole-
cules are identified by the number and position(s) of
heavy isotopes in their constitutive atoms. Most com-
monly the following definitions and terms are used by
researchers in the field of metabolic flux analysis. They are
exemplified for the carbon isotopes 12C and 13C, but can
be generally applied for other isotope labels as well. Posi-
tional isotopomers have an exactly determined labeling pat-
tern with a specific number of 13C atoms in specific
positions of the molecule. Different positional isotopom-
ers thus exhibit identical global isotopic composition but
differ by the position of the heavy atoms in the molecule.
For example, [1-13C] pyruvate and [2-13C] pyruvate are
positional isotopomers with the 13C label at carbon posi-
tions C1 and C2, respectively. Generally, 2n positional iso-
topomers are possible for a compound with n carbons.
Mass isotopomers differ only by the number of heavy atoms
in their molecules, resulting in different molecular
weights. However, they do not differ by the position of the
label. For example, [12C3] pyruvate, [13C-12C2] pyruvate,
[13C2 
12C] pyruvate and [13C3] pyruvate are different mass
isotopomers. Usually, the lightest atoms are not specified
and these mass isotopomers are identified as pyruvate,
[13C] pyruvate, [13C2] pyruvate and [13C3] pyruvate, in
agreement with the International Union of Chemistry. In
mass spectrometric jargon, the corresponding different
mass isotopomer fractions are referred to as M0, M1, M2
and M3 or as m, m+1, m+2 and m+3. When only one ele-
ment of a compound with n such atoms of this element is
labeled, the number of possible mass isotopomers is
(n+1). Most mass isotopomers, except m and m+n,
include multiple positional isotopomers. It should be
noted that the number of positional isotopomers of sym-
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metrical molecules such as succinate is less than 2n. How-
ever, chemically symmetrical molecules may be
biologically asymmetrical because of the configuration of
the active site of enzymes (e.g. the citrate synthase) or
metabolic channeling [1]. The 13C labelling state of a mol-
ecule with n  carbons can be also expressed as molar
enrichment (ME) [2] or as summed fractional labelling
(SFL) [3] describing the weighted sum of mass iso-
topomer fractions (Equation 1).
Introduction
Fluxome analysis aims at the quantitative analysis of in
vivo carbon fluxes in metabolic networks. The experimen-
tal and computational approaches developed in this area
have revealed fascinating insights into various biological
systems. In addition they offered new possibilities as a
rational basis for targeted strain improvement [4,5]. Flux-
ome, i. e. metabolic flux analysis, therefore is in the core
of metabolic engineering [6]. The most wide spread
approaches for fluxome analysis are based on GC-MS
measurement of labelling pattern of metabolites from the
tracer studies performed. Initially developed and applied
mainly in the field of biomedicine [7-10], these GC-MS
based metabolic flux approaches have been substantially
extended and optimized and emerged as a key technology
in metabolic physiology and biotechnology [6,11-15].
State-of art metabolic flux analysis is carried out by a com-
prehensive approach consisting of an experimental and a
computational part (Figure 1). The organism of interest is
hereby cultivated on a substrate, specifically labelled on
certain positions with a stable isotope, mainly 13C. The
labelling patterns of metabolites formed during cultiva-
tion are then measured, whereby, as stated above, GC-MS
is the most used technique today. GC-MS can resolve sin-
gle  mass isotopomers of a compound differing by the
number of labelled atoms and thus allows the measure-
ment of mass isotopomer distributions. The mass iso-
topomer distribution of a compound can be obtained
from the analysis of an ion cluster, which contains the
intact carbon skeleton of the analyte. Similarly mass iso-
topomer distributions can be determined for certain parts
of an analyte considering appropriate fragment ions con-
taining only parts of its carbon skeleton. The mass iso-
topomer distribution can be used to calculate the average
13C enrichment of a molecule, called molar enrichment [2]
or summed fractional labelling [16], via the weighted sum of
mass isotopomer fractions. In selected cases, where a
higher degree of labelling information is required GC-MS
can be also applied to determine positional isotopomers
[16,17]. Like a fingerprint the GC-MS labelling data sensi-
tively reflect the intracellular fluxes and thus can be used
for their calculation. For flux calculation the different
labelling data obtained are usually utilized to globally fit
the unknown flux parameters by a computer flux model
combining isotopomer and metabolite balancing [18-22].
For a given case the flux model contains all relevant reac-
tions and pathways of the investigated metabolic network
with full information on carbon transition in each of the
reactions. Most suitable for the creation of such a flux
model are modelling frameworks with a systematic and
general approach for the quantitative description of the
transfer of labelled 13C atoms in metabolic networks
[14,15]. Starting with a random initial guess for the free
fluxes, the model computes the remaining dependent
fluxes via stoichiometric mass balances and subsequently
calculates the 13C labelling patterns of all compounds in
the network for the given fluxes and compares them with
the experimental labelling data. Applying an optimization
algorithm the deviation of the labelling data between sim-
ulation and experiment is minimized by iterative varia-
tion of the free fluxes until the optimum fit is obtained. In
combination with experimentally determined extracellu-
lar fluxes, absolute carbon fluxes throughout the network
are obtained. With certain constraints GC-MS labelling
data can also be used to calculate local flux ratios in the
network [23,24]. Combination of these flux ratios with a
stoichiometric model and measured extracellular fluxes
also leads to a distribution of absolute fluxes [25]. In
recent years GC-MS has been successfully applied to study
fluxes in bacteria [22,23,26], yeasts [18,27,28], fungi [29],
mammalian cells [30,31] or intact tissues [32,33]. The
wide spread use of GC-MS for metabolic flux analysis is
due to different reasons. GC-MS allows very accurate
quantification of labelling patterns resulting in high accu-
racy and small confidence intervals of the determined
fluxes. Additionally, GC-MS usually provides rich infor-
mation content of the labelling data so that important
fine structures of the metabolic network, e. g. fluxes
through parallel, bidirectional or cyclic fluxes, can be
resolved. The high separation efficiency of GC can resolve
the often complex biological mixtures. Moreover GC-MS
systems are easy to operate and robust. The present review
provides an actual insight into experimental and compu-
tational tools for GC-MS based metabolic flux analysis,
thereby focussing on the currently most important
approach which involves utilization of amino acid label-
ling patterns. Amino acids are often measured instead of
the intermediary metabolites in the central metabolism
since the amino acids in cell extracts and cell protein are
much more abundant than their precursors [16] and pro-
vide extensive labelling information. Knowing the precur-
sor-amino acid relationships it is easy to deduce the
labelling patterns of the precursor metabolites from label-
ling patterns of the amino acids. For the different steps
involved in metabolic flux analysis some practical notes
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and tips are addressed that seem crucial for proper flux
measurements.
GC-MS instrumentation
GC-MS allows the measurement of various metabolites
[34]. This comprises a number of volatiles such as
ketones, aldehydes, alcohols, heterocyclic compounds,
isocyanates, isothiocyanates, sulfides, lipids, and hydro-
carbons up to 12 carbons, which all can be directly meas-
ured. Additionally, various non-volatile or semi-volatile
metabolites including sugars, sugar-phosphates, sugar
alcohols, organic acids, amino acids, lipids, peptides,
long-chain alcohols, alkaloids, amines, amides, etc. are
accessible after derivatization. For flux analysis amino
acids, organic acids and sugar derivates are the most
important compounds to be considered. Currently there
is a wide range of instruments available varying in the type
of ionization and the mass separation (Figure 2). Single-
quadrupole mass spectrometers with electron impact (EI)
ionization are the most often used type of instrument.
Compared to other instruments they are relatively low
cost and offer a range of advantages such as high robust-
ness, high sensitivity and high accuracy of the measured
labelling patterns.
GC separation
The sample solution (usually between 0.1 to 1 μL) is
injected into the GC inlet where it is vaporized and
directed onto the chromatographic column by the carrier
gas (usually helium). The sample molecules are separated
through different interactions between the carrier gas
phase and the stationary phase. To obtain the highest res-
olution in GC-MS analysis, the capillary column should
be carefully chosen. The best general purpose phases are
dimethylsiloxane (DB-1 or equivalent) or 5 % phenyl/
95%dimethlysiloxane (DB-5 or equivalent). These non-
polar phases exhibit an excellent separation capability for
many compounds and a generally low column bleeding.
Polar columns (DB-Wax or equivalent) are useful for
selected derivates such as more polar alkylated com-
pounds. The high separation capacity of GC is illustrated
in Figure 3 for a sample containing various amino acids
and related compounds.
Ionization
The outlet of the GC column is connected via a heated
transfer line with the ion source of the MS where the com-
pounds eluting from the column are ionized. The most
frequently used ionization method is electron impact (EI)
ionization (Figure 4). Hereby the interference of the sam-
ple stream with a crossing electron beam leads to the loss
of an electron from the sample molecules. The resulting
ions with one electron missing, i.e. the molecular ions,
give the total mass of each analyte. Due to the large
amount of energy imparted to the molecular ion it usually
fragments, producing further smaller ions with character-
istic relative abundances that provide a 'fingerprint' for
that molecular structure (Figure 5A). Often the molecular
ion itself is not observed. The different fragment ions may
contain different parts of the carbon skeleton of the ana-
lyte. In the given example for TBDMS-derivatized alanine
the ion cluster [M-57]+at m/z 260 results from loss of a
C4H9 group from the derivatization residue and contains
all three alanine carbon atoms, whereas the ion cluster
[M-85]+ at m/z 232 only contains the carbon atoms C2 and
C3 of alanine due to additional loss of a CO-group includ-
ing the C1 atom of alanine. Chemical ionization (CI) as
alternative ionization method plays a minor role for flux
analysis, but has proven valuable in selected cases such as
labelling analysis of glucose aldonitrile pentaacetate in
different medical flux studies [35-38].
Mass separation
Through a slit the positive ions from the ion source enter
into the mass separation part. Figure 3 shows the most
wide spread type of mass separator in GC-MS analysis, a
quadrupole, composed of four parallel cylindrical rods
(about 25 cm length each), whereby opposite rods are
electrically connected. The mass separation is based on
the motion of ions in an oscillating electric field created
through voltage variation between the rods. At a certain
voltage, only analyte molecules of a distinct mass to
charge (m/z) ratio (resonance ions) can pass and enter the
Strategy for 13C metabolic flux analysis including the experi- mental part with the tracer study and the GC-MS labelling  analysis and the computational part with the simulation of the  labelling data via an isotopomer model representing the  investigated metabolic network Figure 1
Strategy for 13C metabolic flux analysis including the experi-
mental part with the tracer study and the GC-MS labelling 
analysis and the computational part with the simulation of the 
labelling data via an isotopomer model representing the 
investigated metabolic network. The flux estimation is based 
on minimizing the deviation (δ) between the measured and 
the simulated labelling data.Microbial Cell Factories 2007, 6:6 http://www.microbialcellfactories.com/content/6/1/6
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detector, whereas ions exhibiting a different m/z  ratio
(non-resonance ions) are subjected to oscillations causing
their collision with the rods. Within a few seconds the
whole mass range available (usually 50 – 850 m/z) can be
fully scanned. This short time interval required for a full
scan is important, due to the typically narrow peaks elut-
ing from the GC column that have to be scanned several
times each (Figure 3). The sensitivity of a quadrupole
detector can be significantly enhanced by selected ion
monitoring (SIM), whereby only selected masses are
sequentially measured with frequencies of 0.1 to 2 sec-
onds each. The number of collected ions for the selected
masses is increased up to several thousand folds in com-
parison to the scan mode. Quadrupole MS spectra can be
easily compared with commercial or laboratory databases
facilitating the identification of novel compounds and the
validation that a signal is not interfered through isobaric
overlay. In most cases the nominal-mass information pro-
vided by such instruments is sufficient, since the com-
pounds analyzed are a priori known.
Other mass separators available are time-of-flight (TOF)
mass separators or ion traps. In TOF instruments, ions
formed in the ion source are accelerated in a short electric
field to a high kinetic energy, whereby ions with lower
masses reach higher velocities and need a shorter time to
reach the detector. The mass to charge ratio of each ion is
determined from the time elapsed from ion formation to
ion arrival at the detector. This type of mass separation in
GC-TOF-MS systems offers a greater mass accuracy as
compared to a conventional quadrupole. This, however, is
normally not required for the labelling measurement and
does therefore not compensate for the relatively high price
of such instruments. Only the high scan speed possible
allowing multiple scanning of single peaks during their
elution and shortening of analysis time [39] could be ben-
eficial for high-throughput applications or the analysis of
rather complex samples. Alternatively, ion traps can be
applied for mass separation. A drawback of ion traps to be
used for flux analysis is the comparatively low accuracy for
the labelling measurement resulting in a higher uncer-
tainty of the determined fluxes. Relative errors of around
1 % for the most abundant mass peaks [40] are about two
to tenfold higher as compared to that of quadrupole
instruments [15]. An advantage, however, is the possibil-
ity to use the ion trap as a multi stage MSn mass spectrom-
Total ion current (TIC) spectrum of a sample with TBDMS-derivatized metabolites Figure 3
Total ion current (TIC) spectrum of a sample with TBDMS-derivatized metabolites. The separation of the totally 28 com-
pounds is performed on a HP5-MS column (60 m, 250 μm inner diameter, Hewlett-Packard, Avondale, PA).
Overview on different GC-MS instrumentation types Figure 2
Overview on different GC-MS instrumentation types. The 
most frequently used combination in the area of metabolic 
flux studies by isotope labelling is highlighted.Microbial Cell Factories 2007, 6:6 http://www.microbialcellfactories.com/content/6/1/6
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eter which can provide more detailed information on the
labelling pattern. This might be useful in cases, where a
high degree of labelling information is needed to deter-
mine the fluxes of interest [41]. Similarly triple-quadru-
pole instruments can be run as multistage mass
spectrometers. A further variant, useful e.g. for isotope
labelling studies in humans or animals, is isotope ratio
(IR) GC-MS [42,43]. It is based on electron impact ioniza-
tion with maximized ionization probability. IR GC-MS
exhibits an extremely high precision of ± 0.00001 % for
the isotope ratio measurement and is optimal to quantify
low label enrichment [44]. It is, however, limited to the
analysis of gases of high volatility and low reactivity such
as CO2, N2 or SO2. The analytes of interest are transformed
into one of these gases before introduction into the instru-
ment. Usually this provides information only about the
specific labelling enrichment, i.e. the relative abundance
of 13C atoms in the entire molecule. More detailed infor-
mation on number and position of 13C can be obtained,
if all carbon atoms are isolated position specific prior to
measurement as recently shown for position specific 13C
analysis of methyl palmitate through pyrolytic fragmenta-
tion [45].
Labelling analysis with GC-MS
The analysis of the labelling pattern is a central step of
metabolic flux analysis. It has to be ensured that the label-
ling patterns are not affected by the sampling, sample pre-
treatment or the GC-MS analysis itself. The major com-
pounds analyzed by GC-MS for flux analysis are amino
acids [21,22,35,36], organic acids [35,36,46], sugars
[2,37,47], lipids and fatty acids [48]. Moreover, mass dis-
tributions of polymers and their building blocks were
assessed. Examples are glycogen [37,49], cell protein
[16,18,24,50], or DNA[51].
Sampling and sample pre-treatment
Depending on the experiment, the analytes of interest are
cellular polymers (analysis of balanced growth in chemo-
stat or batch processes), free intracellular metabolites
(analysis of process dynamics) or extracellular metabo-
lites in the medium (analysis of production phases with
reduced growth or without growth). Exemplified for
amino acids, the different experimental steps of sampling
and sample pre-treatment for subsequent labelling analy-
sis by GC-MS are given in Figure 6. Free intracellular
amino acids are extracted from the cells, whereby imme-
diate quenching is important to prevent changes in the
labelling pattern during sampling. Due to the high sensi-
tivity of GC-MS only 1 mg cell dry mass are required to
obtain labelling patterns from free intracellular amino
acids [52]. Various quenching and fast sampling methods
described in the literature for metabolome analysis can be
applied here. For bacteria fast filtration with cellulose
nitrate or polyamide filters (0.2 μm pore size) is suitable
[53], whereas yeast cells can be efficiently quenched with
cold buffered methanol [54]. The quenched cells should
be washed to prevent interference with compounds con-
tained in the medium. Metabolite extraction can be per-
formed by incubation in boiling ethanol or in boiling
water. After separation from cell debris the extract is
lyophilized to concentrate the metabolites and remove
the water. For the analysis of amino acids from the cell
protein cells are harvested by centrifugation or filtration,
washed and subsequently hydrolyzed by 24 h incubation
at 110°C in 6 M HCl. During hydrolysis asparagine and
Schematic view of the ion source based on electron impact ionization and the quadrupole mass filter typically found in a GC- MS instrument Figure 4
Schematic view of the ion source based on electron impact ionization and the quadrupole mass filter typically found in a GC-
MS instrument.Microbial Cell Factories 2007, 6:6 http://www.microbialcellfactories.com/content/6/1/6
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glutamine are deaminated to aspartate and glutamate.
Cysteine, methionine and tryptophan are destroyed
through oxidation. If the hydrolysis time is shortened to
about 8 h, signals can be also obtained for e.g. cysteine or
methionine, but at the cost of a generally low yield. The
hydrolysate is neutralized by addition of 6 M NaOH,
whereby often the required volume of NaOH is less than
the volume of HCl due to HCl evaporation during the
Mass spectrum of TBDMS3-alanine derived by electron impact ionization in GC-MS analysis: Naturally labeled alanine with a  mass isotopomer distribution resulting from the nautrally occurring isotopes (A), alanine from the cell protein of S. cerevisiae  cultivated on [1-13C] glucose (B), alanine from the cell protein of lysine producing C. glutamium cultivated on [1-13C] glucose  (C) Figure 5
Mass spectrum of TBDMS3-alanine derived by electron impact ionization in GC-MS analysis: Naturally labeled alanine with a 
mass isotopomer distribution resulting from the nautrally occurring isotopes (A), alanine from the cell protein of S. cerevisiae 
cultivated on [1-13C] glucose (B), alanine from the cell protein of lysine producing C. glutamium cultivated on [1-13C] glucose 
(C). The monoisotopic mass of the molecular ion, which itself is not detected, is 317. The structures of valuable ion clusters 
for labeling analysis in metabolic flux studies (m/z 260, m/z 232) are additionally.Microbial Cell Factories 2007, 6:6 http://www.microbialcellfactories.com/content/6/1/6
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hydrolysis. The pH should be checked, because the subse-
quent derivatization is significantly disturbed by an alka-
line pH. The neutralized hydrolysate is clarified by
filtration, whereby a stable glycerol-free filter material has
to be chosen. Glycerol would be leached out of the filter
and interfere in the later derivatization and GC-MS analy-
sis. Finally the clarified hydrolysate is lyophilized. Extra-
cellular metabolites are harvested by centrifugation
followed directly by lyophilization.
Derivatization
In order for a compound to be analyzed by GC-MS it must
be volatile and thermally stable. Most of the metabolites
utilized for flux analysis are polar or even charged and
thus not sufficiently volatile to be directly analyzed, so
that derivatization is typically required. This holds for
amino acids [16,21,24,50], organic acids [32,35] or sugars
[19,31,37,55,56]. For this purpose a number of straight-
forward derivatization reactions involving silylation,
alkylation or acetylation are available (Table 1). The reac-
Experimental protocols for sampling and processing of amino acids in yeast and bacterial cell extracts, culture supernatant and  biomass (protein) hydrolysate for GC-MS analysis Figure 6
Experimental protocols for sampling and processing of amino acids in yeast and bacterial cell extracts, culture supernatant and 
biomass (protein) hydrolysate for GC-MS analysis.Microbial Cell Factories 2007, 6:6 http://www.microbialcellfactories.com/content/6/1/6
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tions are mainly simple, one-pot conversions with high
yield. More details on derivatization protocols are given in
recent review articles [57-62]. For the analysis of amino
acids, silylation with N-methyl-N-t-butyldimethylsilyl-tri-
fluoro-acetamide (MBDSTFA) is especially useful, since it
leads to derivates which exhibit high signal intensity for
the [M-57] fragment ions. These originate from loss of a t-
butyl group from the derivatization residue, contain the
entire carbon skeleton of the analyte and are thus valuable
for flux calculation [63]. It should be noted that many rea-
gents used are unstable in the presence of water, so that
the aqueous samples, as described above, have to be dried
and re-dissolved in organic solvent prior to derivatization.
It is also possible to directly add the reagent to the lyophi-
lized sample, using an additional solvent such as dimeth-
ylformamide, however, improves the conversion.
Labelling information
The mass isotopomer distribution of a compound can be
directly taken from an ion cluster containing the entire
carbon backbone of the analyte. In many cases these mass
isotopomer distributions sensitively reflect the flux
parameters of interest. This can be illustrated for the prob-
lem of quantifying the flux partitioning at the glucose 6-
phosphate node between the pentose phosphate pathway
(PPP) and glycolysis, important pathways in many micro-
organisms. With [1-13C] glucose as tracer substrate the
labelled carbon atom is completely released as CO2 in the
PPP, whereas the label is completely conserved through
the different glycolytic reactions (Figure 7). The mass iso-
topomer distribution of pyruvate, receiving carbon from
both pathways, thus significantly changes with a variation
of the flux partitioning. As revealed by metabolic simula-
tions an increase of the relative flux into the PPP is
reflected by a decrease of the fraction of single labelled
pyruvate and an increase of the fraction of non-labelled
pyruvate. GC-MS measurement of the labelling of pyru-
vate or pyruvate derived metabolites such as alanine
allows precise estimation of PPP and glycolytic flux. This
becomes obvious from mass spectra of TBDMS-deriva-
tized alanine from tracer experiments of a lysine produc-
ing Corynebacterium glutamicum mutant (Figure 5B) and
Saccharomyces cerevisiae (Figure 4C) cultivated on 99 % [1-
13C] glucose in batch culture. In both cases the heavier
mass isotopomer fractions, e.g. at the ion cluster m/z 260,
are increased due to the enrichment with 13C. In compar-
ison with S. cerevisiae the fraction of single labelled
alanine is markedly reduced in C. glutamicum revealing a
significantly higher flux through the PPP in this organism,
which is related to the increased NADPH demand for
lysine production. Similarly mass isotopomer distribu-
tions of other metabolites give access to various other flux
parameters, such as dual pathways in amino acid biosyn-
thesis [64], bidirectional fluxes around the pyruvate node
[64] or parallel pathways in different cellular compart-
ments [18] and different flux ratios [24]. In other studies,
summed fractional labelling data have been utilized for
the analysis of fluxes [65,66]. Hereby, the lower degree of
information for each single compound was compensated
by the consideration of different ion fragments containing
different parts of the carbon skeleton for the analytes [67].
More detailed information on the labelling of a com-
pound can be obtained with GC-MS via additional analy-
sis of fragment ions, which contain only specific parts of
the carbon skeleton of the analyte. As example, the entire
positional isotopomer distribution of pyruvate can be
determined by GC-MS via analysis of four ion clusters of
its methyl-ester derivate [17] or via GC-MS analysis of dif-
ferent ions of pyruvate derived amino acids valine and
alanine [16]. More complex protocols may be required for
analytes containing more carbon atoms, thus exhibiting a
substantially increased number of possible positional iso-
Table 1: Derivatization methods for GC-MS analysis of metabolites
Analyte Derivatization Reagent
Alcohols Silylation trifluoroacetamides (BSA, MSTFA, BSTFA, MBDSTFA)
Phenols Acylation activated carboxylates (ECF, TFAA)
Alkylation activated methyl groups (TMAH, TMSH, DMFDMA)
Amines (primary, secondary) Silylation trifluoroacetamides (BSA, MSTFA, MSHFBA)
Acylation activated carboxylates (TFAA, HFBA, MBTFA)
Amino acids Silylation trifluoroacetamides (MBDSTFA, BSA, BSTFA)
Alkylation + Acylation MeOH/TMCS, TMSH, DMFDMA + TFAA, HFBA, ECF, TFAA,
Carboxylic Acids Silylation trifluoroacetamides (BSA, MSTFA, MSHFBA, TSIM)
Alkylation activated methyl groups (TMAH, TMSH, DMFDMA)
a-keto acids Oximation + Silylation hydroxylamine, O-ethylhydroxylamine + trifluoroacetamides (BSA, MSTFA, BSTFA, 
MBDSTFA)
Thiols Acylation activated carboxylates (ECF, TFAA)
Alkylation activated methyl groups (TMAH, TMSH, DMFDMA)
Carbohydrates Oximation + Silylation hydroxylamine, O-ethylhydroxylamine + trifluoroacetamides (BSA, MSTFA, BSTFA)
Silylation trifluoroacetamides (BSA, MSTFA, BSTFA)
Acylation activated carboxylates (TFAA, MBDTFA)Microbial Cell Factories 2007, 6:6 http://www.microbialcellfactories.com/content/6/1/6
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topomers. The determination of 24 out of 32 positional
isotopomers of glutamate involves chemical and enzy-
matic synthesis of five different derivates of glutamate
prior to GC-MS analysis [36]. Also other protocols for res-
olution of positional isotopomer pools are rather labori-
ous and include various steps for purification and
chemical or enzymatic conversion of the analytes
[35,49,68,69] which impedes the broad and routine use
of such techniques. It should be noticed that the resolu-
tion of single positional isotopomer pools not necessarily
leads to an increase in information for flux quantification
[67,70], but in selected cases single isotopomer pools
might be required to calculate all fluxes of interest. A
major tool to obtain additional fragments towards posi-
tional isotopomer analysis is targeted fragmentation using
MS/MS, also called tandem MS, where selected ions can
be isolated, subsequently fragmented and the fragments
can be analyzed for their mass distribution. The potential
of such approaches for flux analysis is underlined by
recent studies [71,72].
Correction for natural isotopes
To calculate the 13C labelling of a molecule from a GC-MS
measurement, the data have to be corrected for natural
isotopes. Hereby, atoms of the analyte and of added deri-
vatization residues have to be considered. Natural iso-
topes typically occurring in GC-MS are carbon, hydrogen,
nitrogen, oxygen and silicium (Table 2). Mathematically,
the presence of natural isotopes can be considered by cor-
rection matrices [17,73-75]. Straightforward is the 'addi-
tion' of the natural isotopes to the simulated data during
flux calculation and the direct comparison with the meas-
urement data [17]. Alternatively the natural isotopes can
be 'subtracted' from the measurement signals to obtain
the labelling of the carbon skeleton of the analyte and
compare this value with the corresponding simulated data
during flux calculation [76].
Guidelines for optimal labelling measurement
Quantitative accuracy of the measurement is crucial for
mass isotopomer analysis. Several sources of error may
potentially affect the measurement result and should
therefore be taken into account. First the signals have to
be checked for purity, i.e. that isobaric interference of the
analytes with co-eluting compounds does not occur. For
the consistency check of GC-MS mass isotopomer distri-
butions several efficient software tools have been devel-
oped [25,76,77]. A check can also be done experimentally
by an additional cultivation on naturally labelled sub-
strate in parallel to the tracer experiment and comparison
of the mass isotopomer distributions from this study with
theoretically expected values, calculated from the natural
abundance of isotopes or experimental values from pure
standard compounds. Another potential cause of inaccu-
racy is incomplete resolution of adjacent ions due to ion
scattering and peak tailing. Therefore the mass spectrom-
eter (lens system, quadrupole pre-filter, quadrupole rods,
detector) has to be tuned to enable optimum mass-resolv-
ing capacity [50]. To obtain optimal signal intensity and
avoid interference the signal for each mass isotopomer
should be collected in SIM mode from the maximum of
each mass peak. The m/z value at the peak maximum typ-
ically deviates from an integer value due to underlying
atom masses contained in the ion. Nonlinearity of the
detector response at different mass isotopomer ratios or
Table 2: Isotopic compositions of biologically relevant elements [129].










H 1 0.999885 0.000115
C 12 0.9893 0.0107
N 14 0.99632 0.00368
O 16 0.99757 0.00038 0.00205
Si 28 0.922297 0.046832 0.030872
S 32 0.9493 0.0076 0.0429 0.0002
Quantification of the flux partitioning between pentose phos- phate pathway (PPP) and glycolysis: Carbon transfer from [1- 13C] glucose in the underlying metabolic reactions (A), Influ- ence of a variation of the relative flux into the PPP on the rel- ative abundance of non labelled (M0) and single labelled (M1)  pyruvate as determined by simulation with an isotopomer  model (B) Figure 7
Quantification of the flux partitioning between pentose phos-
phate pathway (PPP) and glycolysis: Carbon transfer from [1-
13C] glucose in the underlying metabolic reactions (A), Influ-
ence of a variation of the relative flux into the PPP on the rel-
ative abundance of non labelled (M0) and single labelled (M1) 
pyruvate as determined by simulation with an isotopomer 
model (B).Microbial Cell Factories 2007, 6:6 http://www.microbialcellfactories.com/content/6/1/6
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different analyte amounts may further lead to false results
[78]. Whereas such effects are observed for fatty acid
methyl esters, mass isotopomer ratios of naturally
labelled TBDMS-amino acids were not affected over a con-
centration range of 3 orders of magnitude [50]. Interfer-
ence with background noise leads to false results for low
abundance signals which therefore should not be consid-
ered for flux calculation. The same holds for signals above
the saturation of the detector which underestimate the rel-
ative abundance of the most prominent mass isotopomer
fractions. Such effects can be visualized by an inhomoge-
neous peak composition [50]. Reduction of the electron
multiplier voltage (EMV) at the detector or sample dilu-
tion may compensate for such effects. One should further
consider that the efficiency of electron multipliers can sig-
nificantly decrease with life time. This can lead to a drift
of the measured labelling pattern, i.e. mass isotopomer
ratio, with increasing EMV or sample amount (Figure 8A).
In such cases the multiplier should be changed. The high
separation capacity of GC leads to isotope discrimination,
as shown by the elution behaviour of the different mass
isotopomers of TBDMS3-glutamate (Figure 8B). To ade-
quately consider all mass isotopomers of a compound
and obtain meaningful results, the average mass spectrum
of the whole peak range has to be considered. This leads
to a significantly reduced signal-to-noise ratio that
excludes the use of labelling data from low abundance
fragments [50].
Experimental design, modelling and flux 
calculation
Metabolic flux analysis with GC-MS is usually performed
as stationary flux analysis, whereby the metabolism is in
metabolic and isotopic steady-state. Application examples
are chemostat cultures [41] or batch cultures with bal-
anced growth [4,23,66]. Additionally novel approaches
have been developed to study fluxes also under non-
steady-state conditions [79].
Network topology
Generally, metabolic flux analysis by isotope labelling
experiments requires a known topology of the biochemi-
cal network. Topological phenomena, such as metabolite
channelling, compartmentation or zonation, mainly
observed in eukaryotic systems, may influence the fate
and the labelling pattern of metabolites in the network
and must be considered, when interpreting obtained
labelling data [80]. Metabolite channelling can prevent
label scrambling of symmetric intermediates through ori-
entation-conserved biocatalytic reactions as found for
mitochondrial TCA cycle enzymes in mammalian cells
[81] and yeast [82] and for pentose phosphate pathway
(PPP) enzymes in yeast [83]. The compartments in
eukaryotic cells lead to spatially separated metabolite
pools and reactions, which has significant impact on
labelling patterns. As example amino acid metabolism in
yeast may occur in the cytosol, the mitochondrium or in
both compartments, whereby the pathway location may
vary between different species [84,85] or with cultivation
conditions [18]. In tissue cultures zonation of metabolic
activities may lead to heterogeneous labelling patterns as
described for triose phosphate pools in rat liver [86]. The
significant impact of metabolite channelling, compart-
mentation or zonation on labelling patterns, requesting
their consideration in flux analysis, can be exploited by
using isotope labelling studies to unravel these important
features in biological systems [87]. Evidence for isotope
effects on rate and equilibrium of metabolic reactions has
not been gained, so that it appears justified to neglect
them [16].
The majority of GC-MS based flux approaches utilizes
amino acid labelling patterns [16,50,85,88-90]. Knowing
the precursor-amino acid relationships it is easy to deduce
the labelling patterns of the precursor metabolites from
labelling patterns of the amino acids. The relationship
between precursor compounds from glycolysis, pentose
phosphate pathway and TCA cycle and the amino acids
for E. coli, C. glutamicum, B. subtilis, P. putida and S. cerevi-
siae is given in Figure 9. Except for lysine the synthesis of
all amino acids is identical in all these microorganisms
[91]. In E. coli, B. subtilis and P. putida one lysine biosyn-
thetic route is available each from oxaloacetate and pyru-
vate, respectively, which includes a symmetric
Influence of the life-time of the electron multiplier (A) and of  isotope discrimination effects during the GC separation (B)  on GC-MS labelling analysis Figure 8
Influence of the life-time of the electron multiplier (A) and of 
isotope discrimination effects during the GC separation (B) 
on GC-MS labelling analysis. The effect of the electron multi-
plier is exemplified for the ratio between the single and the 
non labelled mass isotopomer fraction of naturally labelled 
TBDMS2-alanine whereby the dashed line represents the the-
oretical value and the experimental values result from meas-
urement using an electron multiplier with extended life time 
and a new electron multiplier, respectively. The isotope dis-
crimination effects are given for the different mass isotopom-
ers of TBDMS3-glutamate.Microbial Cell Factories 2007, 6:6 http://www.microbialcellfactories.com/content/6/1/6
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intermediate that results in label scrambling. Bakers's
yeast utilizes a-ketoglutarate and acetyl-CoA as lysine pre-
cursors. C. glutamicum possesses two alternative pathways
for lysine biosynthesis, whereby the in vivo activity of the
two branches can vary with cultivation conditions or
genetic modifications [92]. One should note that serine
and glycine may not exclusively originate from their well
known precursor 3-phosphoglycerate, but can also be
formed from oxaloacetate via the threonine pathway and
threonine aldolase [4,66].
Choice of tracer substrates
The resolution of intracellular fluxes is strongly depend-
ent on the 13C-labeling strategy. In GC-MS based
approaches the use of [1-13C] glucose as well as the use of
a mixture of [13C6] glucose and unlabeled glucose has
proven useful to resolve important fluxes throughout the
central metabolism in different organisms. Concerning
the central metabolic pathways, a mixture of [13C6] glu-
cose and unlabeled glucose is particularly useful to resolve
fluxes downstream of PEP and some exchange fluxes that
result in C-C bond cleavages, whereas the use of [1-13C]
glucose is valuable for resolving the upper part of metab-
olism, in particular the oxidative PP pathway, glycolysis
and the Entner-Doudoroff pathway [24]. Combining [U-
13C] glucose and [1-13C] glucose, either in two separate
experiments [19,21,24] or as a substrate mixture [20] may
lead to an even better resolution of fluxes in the network.
The resolution of a particular flux, however, depends on
the network topology itself so general guidelines cannot
be given. Questions concerning the determinability and
the predicted accuracy of a certain flux together with an
Relationship between the carbon skeleton of amino acids and the carbon skeleton of their metabolic precursors for the ana- bolic pathways in E. coli, S. cerevisiae, C. glutamicum and B. subtilis Figure 9
Relationship between the carbon skeleton of amino acids and the carbon skeleton of their metabolic precursors for the ana-
bolic pathways in E. coli, S. cerevisiae, C. glutamicum and B. subtilis. The data are partly taken from [130].Microbial Cell Factories 2007, 6:6 http://www.microbialcellfactories.com/content/6/1/6
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optimal experimental approach can be effectively
answered by computer based experimental design
[64,70,93]. One should note that the flux calculation is
rather sensitive to the mixing ratio of two differently
labelled compounds applied at the same time, e.g. [13C6]
glucose and naturally labelled glucose. This mixing ratio
should be exactly known, considering the facts that during
storage some labelled compounds are hygroscopic. For
glucose this can be taken into account by 8 h drying at
80°C prior to weighting.
Flux calculation, statistics and goodness of fit
The flux parameters are usually estimated from the 13C
tracer studies data by minimization of the deviation
between experimental and simulated labelling data using
numerical routines [15] Hereby, the free flux parameters
of interest, such as flux partitioning ratios or reversibilities
are varied by the optimization function starting from ini-
tial values until an acceptable agreement between experi-
mental and simulated labelling patterns is achieved.
Different optimization functions such as gradient or adap-
tive random search functions are available. To increase the
probability of the identification of a global optimum for
the solution, the convergence is usually tested for different
initial guesses. As error criterion a weighted sum of least
squares (SLS) is typically used (Equation 2).
By this, the differences between experimental (rexp) and
calculated (rcalc) labelling data, e. g. molar fractions of
mass isotopomers ratios, are normalized and the resulting
relative experimental errors of the corresponding MS
measurements (sr,i) are used for weighting. As a result,
data with relatively small error contribute to a higher
extent, whereas the influence of data with a relatively high
error and uncertainty has only a minor influence on the
overall optimization result. Statistical analysis is of great
importance in order to identify whether differences
observed for intracellular flux distributions between dif-
ferent experiments can be really attributed to strain or
condition specific differences. Such analysis can be per-
formed by a Monte-Carlo approach including multiple
parameter estimation runs with statistical variation of the
experimental data [94,95]. The statistical variation is done
such that random errors are added to the data sets, assum-
ing a normal distribution of measurement errors around
previously obtained mean values. Subsequently, multiple
parameter estimations are carried out for each scenario,
yielding multiple flux distributions with a corresponding
mean value and a standard deviation for each intracellular
flux parameter, from which confidence limits for the sin-
gle parameters can be calculated. The high accuracy of
intracellular fluxes determined by GC-MS based flux anal-
ysis is illustrated by a phase plane plot for different
mutant strains of C. glutamicum (Figure 10). Based on pre-
vious experimental data [21] 250 independent estimates
for the PPP and the TCA cycle flux with statistically varied
experimental data for each strain show that, despite the
strains differ only gradually in the corresponding fluxes,
clear differentiation is possible. This is a great advantage
as compared to NMR based flux approaches resulting in
much higher uncertainty of intracellular fluxes [21]. Flux
analysis using GC-MS allows a high goodness of fit, if all
critical steps of the comprehensive approach are carefully
addressed [19,21,22]. High deviation in selected mass iso-
topomer distributions leaves the estimated fluxes ques-
tionable. Such deviations may point at underlying errors
in the performed study. Potential sources of errors include
the labelling measurement itself, assumptions in the net-
work topology, e.g. on available pathways, or carbon
transfer in the underlying reactions, or simply errors in the
complex metabolic model. Simulated and experimental
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Statistical analysis of metabolic fluxes using a Monte-Carlo  approach exemplified for flux through major NADPH gener- ating pathways, the pentose phosphate pathway (PPP) and  the TCA cycle Figure 10
Statistical analysis of metabolic fluxes using a Monte-Carlo 
approach exemplified for flux through major NADPH gener-
ating pathways, the pentose phosphate pathway (PPP) and 
the TCA cycle. The calculation is based on a previous flux 
study of different lysine producing strains of C. glutamicum 
[21] and represents 250 independent flux estimations with 
statistically varied experimental data for each of the five 
strains shown.Microbial Cell Factories 2007, 6:6 http://www.microbialcellfactories.com/content/6/1/6
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display important information that should always be
included in the presentation of flux studies.
Metabolic flux studies using GC-MS
The following chapter shows the application of GC-MS to
metabolic flux analysis by different examples and should
illustrate the broad application potential of such
approaches in different fields of research. Whereas some
of the examples focus on flux quantification of only a sin-
gle or a few selected reactions, others aim at the analysis
of larger parts of the metabolism.
Bacteria, yeasts and fungi
GC-MS based metabolic flux analysis has been applied to
various microorganisms. This includes several flux studies
of E. coli, one of the most prominent model organisms. As
example, different mutants were studied at miniaturized
scale providing information on gene function [23]. Meta-
bolic flux analysis utilizing GC-MS was used also to inves-
tigate the adaptation of E. coli to the loss of key metabolic
enzymes [96], the function of soluble and membrane
bound transhydrogenase [97] or growth on different sub-
strates [26]. Additionally, the effect of single gene deletion
on metabolic fluxes has been studied applying a combina-
tion of GC-MS and NMR for labelling analysis [26,98-
102]. A number of studies have been carried out for the
industrial amino acid producer C. glutamicum, providing
important knowledge for rational strain improvement.
This microorganism has been investigated with respect to
the influence of different substrates in batch culture
[19,22], fluxes in chemostat culture under substrate limi-
tation [41], the comparison of different lysine producing
mutants [4,21,103] and different phases of a production
process [20]. Further prokaryotes studied on the level of
intracellular carbon flux using GC-MS based approaches
are Bacillus subtilis [79,104], Bacillus clausii [105]or Strepto-
myces noursei [106]. In another study flux ratio analysis
was applied to compare fluxes in Pseudomonas putida,
Zymononas mobilis,  Sinorhizobium meliloti,  Rhodobacter
sphaeroides and Lactococcus versutus [107]. Among yeasts
studied on the level of intracellular fluxes by GC-MS are
Saccharomyces cerevisiae with studies on the influence of
growth rate [18,27], or the comparison of different
mutants [66], several members of the genus Pichia
[84,88,108], Phaffia rhodozyma [28] or different other spe-
cies [109]. Flux studies with fungi comprise e. g. biotech-
nologically relevant species such as Penicillium
chrysogenum  [29], Aspergillus nidulans [65] or Aspergillus
niger [95].
Mammalian cell cultures, tissues, animals and humans
Isotopic tracer experiments with GC-MS labelling analysis
are utilized in the biomedical area field since many years
[12,13]. Flux studies in this field significantly contributed
to our current understanding on metabolic function in
mammalian cell lines or organs or on the underlying
metabolism related to diseases [110]. The inherent com-
plexity of the networks with different compartments or
tissue zones, metabolite channelling and complex dilu-
tion effects of the labelling often restricts the determina-
tion by a tracer experiment to selected flux parameters
[15]. Flux studies of mammalian cell cultures comprise
e.g. the comparison of different cell lines [30], the influ-
ence of butyrate on differentiation of adenocarcinoma
cells [55], or the response of fasted rat hepatocytes to dif-
ferent substrates [31]. Extensive work has been carried out
on quantifying fluxes in the central metabolism of tissue
cultures. This involves studies on the pentose phosphate
pathway in human hepatoma cells [111], or on anaplero-
sis, cataplerosis and the TCA cycle in perfused rat liver
[35,36,112], and rat heart [32,113,114]. Another impor-
tant application of stable isotopes and GC-MS is the in
vivo quantification of polymer biosynthesis as exempli-
fied by studies on DNA synthesis in rats [51,115,116],
protein turn-over in humans [117] or lipidogenesis in
humans [118]. Hereby, a mathematical approach is
applied that allows the calculation of the labelling of the
actual precursor molecules of a particular polymer [119-
121].
Outlook
Due to high robustness, sensitivity and versatility, GC-MS
based approaches will play a central role as routine tech-
nology for future analysis of metabolic fluxes in various
biological systems. The use of stable isotopes in combina-
tion with GC-MS for metabolic flux analysis will establish
as important method in actual fields such as functional
genomics, systems biology, and pharmaceutical research
for drug development [122,123]. The compatibility with
miniaturized cultivation tools will hereby allow the appli-
cation to broad sets of mutants or cultivation conditions
[24,103,124]. In addition to GC-MS also other mass spec-
trometry techniques, recently coming into focus, will be
important tools for flux analysis. This involves LC-MS
with excellent characteristics for dynamic flux measure-
ments via labelling patterns of intracellular metabolites
[71,125-127] or MALDI-TOF MS with ultra-fast measure-
ment at low experimental effort [128] providing an out-
standing innovation for high-throughput flux analysis e.g.
of mutant libraries or culture conditions [124].
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